SEC Form 4 · accession 0001192482-15-000207
COLLEGIUM PHARMACEUTICAL, INC · COLL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Patrick J Heron
Director · 10% Owner
Period of report
May 12, 2015
Accepted (ET)
May 14, 2015 · 4:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001267565
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F3 | May 12, 2015 | C | 582,490 | — | A | 582,490 | I | By Frazier Healthcare VI, L.P. |
| Common StockF1,F2,F3 | May 12, 2015 | C | 222,231 | — | A | 804,721 | I | By Frazier Healthcare VI, L.P. |
| Common StockF1,F2,F3 | May 12, 2015 | C | 392,113 | — | A | 1,196,834 | I | By Frazier Healthcare VI, L.P. |
| Common StockF1,F2,F3 | May 12, 2015 | C | 540,498 | — | A | 1,737,332 | I | By Frazier Healthcare VI, L.P. |
| Common StockF3 | May 12, 2015 | P | 150,000 | $12.00 | A | 1,887,332 | I | By Frazier Healthcare VI, L.P. |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series A Convertible StockF3,F1,F2 | — | May 12, 2015 | C | 4,019,183 | D | — | — | Common Stock | 582,490 | 0 | I |
| Series B Convertible StockF3,F1,F2 | — | May 12, 2015 | C | 1,533,399 | D | — | — | Common Stock | 222,231 | 0 | I |
| Series C Convertible StockF3,F1,F2 | — | May 12, 2015 | C | 2,705,585 | D | — | — | Common Stock | 392,113 | 0 | I |
| Series D Convertible StockF3,F1,F2 | — | May 12, 2015 | C | 3,676,078 | D | — | — | Common Stock | 540,498 | 0 | I |
Explanation of responses
- F1All series of Convertible Preferred Stock automatically converted into Collegium Pharmaceutical, Inc. common stock on a 1-for-6.9 basis immediately prior to the closing of the initial public offering and had no expiration date.
- F2Reflects the conversion of preferred stock into Collegium Pharmaceutical, Inc. common stock on a 1-for-6.9 basis which became effective on May 12, 2015.
- F3The shares are held by Frazier Healthcare VI, L.P. The general partner of Frazier Healthcare VI, L.P. is FHM VI, L.P., a limited partnership, the general partner of which is FHM VI, LLC. The members of FHM VI, LLC are Dr. Nathan Every, Alan Frazier, Nader Naini, Patrick Heron, and Dr. James Topper. These individuals share voting and investment power over the shares held by Frazier Healthcare VI, L.P. Mr. Heron disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest.